These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


809 related items for PubMed ID: 24480999

  • 1. Impact of HLA antibodies on graft survival in long-term renal recipients with functional grafts.
    Zeng Y, Liu Z, Liu Y, Fan Y, Guo Y, Qiu J.
    Urol Int; 2014; 92(3):328-33. PubMed ID: 24480999
    [Abstract] [Full Text] [Related]

  • 2. Role of human leukocyte antigen, donor-specific antibodies, and their impact in renal transplantation.
    Thiyagarajan UM, Bagul A, Frost J, Horsburgh T, Nicholson ML.
    Transplant Proc; 2012 Jun; 44(5):1231-5. PubMed ID: 22663991
    [Abstract] [Full Text] [Related]

  • 3. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL, Jin XB, Li XT, Wang HW, Lü JJ.
    Chin Med J (Engl); 2009 Feb 20; 122(4):420-6. PubMed ID: 19302748
    [Abstract] [Full Text] [Related]

  • 4. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
    Tsapepas DS, Vasilescu R, Tanriover B, Coppleson Y, Rekhtman Y, Hardy MA, Dube G, Crew RJ, Ratner LE, Cohen DJ, Mohan S.
    Transplantation; 2014 Mar 27; 97(6):642-7. PubMed ID: 24637863
    [Abstract] [Full Text] [Related]

  • 5. Clinical significance of post kidney transplant de novo DSA in otherwise stable grafts.
    Cooper JE, Gralla J, Chan L, Wiseman AC.
    Clin Transpl; 2011 Mar 27; ():359-64. PubMed ID: 22755431
    [Abstract] [Full Text] [Related]

  • 6. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML, Ahsan N, Wadei HM, Genco PV, Geiger XJ, Willingham DL, Taner CB, Hewitt WR, Grewal HP, Nguyen JH, Hughes CB, Gonwa TA.
    Transplantation; 2009 Jan 27; 87(2):227-32. PubMed ID: 19155977
    [Abstract] [Full Text] [Related]

  • 7. Long-term outcomes of kidney transplantation across a positive complement-dependent cytotoxicity crossmatch.
    Riella LV, Safa K, Yagan J, Lee B, Azzi J, Najafian N, Abdi R, Milford E, Mah H, Gabardi S, Malek S, Tullius SG, Magee C, Chandraker A.
    Transplantation; 2014 Jun 27; 97(12):1247-52. PubMed ID: 24854670
    [Abstract] [Full Text] [Related]

  • 8. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC, Ozawa M.
    Clin Transpl; 2007 Jun 27; ():219-26. PubMed ID: 18642453
    [Abstract] [Full Text] [Related]

  • 9. Detailed examination of HLA antibody development on renal allograft failure and function.
    Zhu L, Lee PC, Everly MJ, Terasaki PI.
    Clin Transpl; 2008 Jun 27; ():171-87. PubMed ID: 19711514
    [Abstract] [Full Text] [Related]

  • 10. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.
    Lachmann N, Terasaki PI, Budde K, Liefeldt L, Kahl A, Reinke P, Pratschke J, Rudolph B, Schmidt D, Salama A, Schönemann C.
    Transplantation; 2009 May 27; 87(10):1505-13. PubMed ID: 19461487
    [Abstract] [Full Text] [Related]

  • 11. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
    Solgi G, Furst D, Mytilineos J, Pourmand G, Amirzargar AA.
    Transpl Immunol; 2012 Mar 27; 26(2-3):81-7. PubMed ID: 22182633
    [Abstract] [Full Text] [Related]

  • 12. The clinical significance of human leukocyte antigen antibody development in kidney transplantation.
    Lee PC, Chen YL, Chou TC, Wang WM, Wang JD, Hung CJ, Chang SS, Lin YJ, Chan RH.
    Transplant Proc; 2012 Jan 27; 44(1):264-6. PubMed ID: 22310628
    [Abstract] [Full Text] [Related]

  • 13. Long-term post transplant alloantibody monitoring: a single center experience.
    Ntokou IS, Boletis JN, Apostolaki M, Vrani V, Zavos G, Kostakis A, Iniotaki A.
    Clin Transpl; 2011 Jan 27; ():341-50. PubMed ID: 22755429
    [Abstract] [Full Text] [Related]

  • 14. Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules.
    Ntokou IS, Iniotaki AG, Kontou EN, Darema MN, Apostolaki MD, Kostakis AG, Boletis JN.
    Transpl Int; 2011 Nov 27; 24(11):1084-93. PubMed ID: 21848902
    [Abstract] [Full Text] [Related]

  • 15. Higher Serum Trough Levels of Tacrolimus Increase 5-Year Allograft Survival in Antibody Positive Renal Transplant Patients.
    Peng ZG, Tian J.
    Clin Transpl; 2014 Nov 27; ():209-14. PubMed ID: 26281147
    [Abstract] [Full Text] [Related]

  • 16. Early Intervention in Living Kidney Transplantation Based on Dynamic Monitoring of Donor Specific Antibodies.
    Chen Y, Li LY, Lou XY, Wang H, Zhang L, Zhu YH.
    Clin Transpl; 2014 Nov 27; ():205-8. PubMed ID: 26281146
    [Abstract] [Full Text] [Related]

  • 17. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
    Waki K, Sugawara Y, Mizuta K, Fujita H, Kadowaki T, Kokudo N.
    Clin Transpl; 2011 Nov 27; ():223-35. PubMed ID: 22755416
    [Abstract] [Full Text] [Related]

  • 18. Influence of preoperative anti-HLA antibodies on short- and long-term graft survival in recipients with or without rituximab treatment.
    Ishida H, Furusawa M, Shimizu T, Nozaki T, Tanabe K.
    Transpl Int; 2014 Apr 27; 27(4):371-82. PubMed ID: 24438437
    [Abstract] [Full Text] [Related]

  • 19. Human leukocyte antigen and major histocompatibility complex class I-related chain A antibodies after kidney transplantation in Turkish renal transplant recipients.
    Seyhun Y, Ozdilli K, Oguz F, Karahan G, Onal E, Turkmen A, Eldegez U, Nane I, Çalişkan Y, Bakkaloglu H, Carin M.
    Transplant Proc; 2012 Apr 27; 44(6):1660-6. PubMed ID: 22841239
    [Abstract] [Full Text] [Related]

  • 20. Highly Sensitized Patients: Miami Transplant Institute Experience.
    Mattiazzi AD, Centeno A, Amador A, Fernandez-Bango C, Scowby CD, O'Rourke M, Hill-Matthie T, Patel R, Barrios F, Ruiz P, Chen L, Saghesima J, Ciancio G, Burke GW, Goldstein M, Chandar J, Contreras G, Roth D, Kupin W, Guerra G, Vianna R.
    Clin Transpl; 2014 Apr 27; ():171-8. PubMed ID: 26281142
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 41.